Long-Term Prognostic Impact of the Use of Erythropoietic-Stimulating Agents in Patients With Chronic Myeloid Leukemia in Chronic Phase Treated With Imatinib

BACKGROUND: Anemia is a frequent side effect of imatinib in patients with chronic myeloid leukemia (CML). Erythropoietic-stimulating agents have been used for treatment of imatinib-induced anemia. There are no data on long-term safety of erythropoietic-stimulating agents in CML patients. METHODS: Th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer
Main Authors: Santos, Fabio P. S., Alvarado, Yesid, Kantarjian, Hagop, Verma, Dushyant, O’Brien, Susan, Mattiuzzi, Gloria, Ravandi, Farhad, Borthakur, Gautam, Cortes, Jorge
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4324729/
https://ncbi.nlm.nih.gov/pubmed/20960502
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.25533
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados